Hematology Archives - Page 2 of 5

Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling

Authors: R D Ballal, M F Botteman, I Foley, J M Stephens, C T Wilke, A V Joshi Published: Current Medical Research and Opinion, 2008 View publication Objectives People with severe hemophilia...

Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia

Authors: P Cornes, J Kelton, R Liu, O Zaidi, J Stephens, J Yang Published: Future oncology (London, England), 2022 View publication Background Real-world data suggests superiority of pegfilgrastim (PEG) over filgrastim (FIL)...

The UK Paediatric Familial Hypercholesterolaemia Register: Preliminary data

Authors: Uma Ramaswami, Jackie Cooper, Steve E Humphries, on behalf of the FH Paediatric Register Steering Group Published: Archives of disease in childhood, 2016 View publication Background The National Institute for Health...

The impact of introduction of novel oral anticoagulants (NOACs) into a general practice and a hospital anticoagulant service: two local service evaluations

Authors: Tom Cahill, Julie Broughton, Josephine Hough, Stephen Jenkins Published: British journal of Healthcare Management, 2019 View publication Background/Aims Anticoagulants are indicated for stroke prevention in nonvalvular atrial fibrillation, and treatment and...

Health-related quality of life and productivity/activity impairment in patients with transfusion-dependent B-thalassaemia in the UK NHS: Data from a UK Multicentre observational study

Authors: K Ryan, S Pancham, P Telfer, F Shah, J Kell, S Pollard, R Wynn, M Velangi, E Chalmers, J Hickey, C Paramore, M Jobanputra Published: Value in Health, 2019 View publication...

Routine management, healthcare resource use and patient/caregiver reported outcomes of patients with transfusion-dependent β thalassaemia in the United Kingdom: A mixed methods observational study

Authors: F Shah, P Telfer, M Velangi, S Pancham, R Wynn, S Pollard, E Chalmers, J Kell, J Hickey, C Paramore, M Jobanputra, K Ryan Published: Blood, 2019 View publication Abstract Patients...

Survivorship in acquired thrombotic thrombocytopenic purpura (aTTP) – impacts on quality of life (QoL) and cognitive functioning in patients from the UK

Authors: S Holmes, L Podger, J Bernarde, C Bottomley, F Chandler Published: 2020 View publication Background Acquired or immune-mediated TTP is a life-threatening illness affecting adults aged in their mid-40s. Disease onset...

Real world effectiveness of thrombopoietin receptor agonists (TRAs) in the management of immune thrombocytopenia (ITP) in the UK: results from a post-hoc analysis of the TRAIT study

Authors: N Cooper, D Provan, M Scully, P L R Nicolson, C Percy, C Bagot, J Thachil, Q A Hill, T Nokes, H Grech, C Bradbury, T Dutt, K Talks, G Evans,...

Patient and caregiver preferences for Haemophilia A treatments: a discrete choice experiment

Authors: J Su, N Li, N Joshi, X Ng, M Botteman, R Shah, N Jain, N Lyn, R Preblick Published: Haemophilia: the official journal of the World Federation of Hemophilia, 2020 View...

News